Leaky gut and diabetes mellitus: what is the link?

被引:182
作者
de Kort, S. [1 ]
Keszthelyi, D. [1 ]
Masclee, A. A. M. [1 ]
机构
[1] Maastricht Univ, Med Ctr, Div Gastroenterol Hepatol, Dept Internal Med, NL-6202 AZ Maastricht, Netherlands
关键词
Barrier function; diabetes mellitus; gastrointestinal tract; insulin resistance; INCREASED INTESTINAL PERMEABILITY; GLUCAGON-LIKE PEPTIDE-2; TREATMENT PARTIALLY PROTECTS; GLUTEN-FREE; INSULIN-RESISTANCE; INTERFERON-GAMMA; BARRIER FUNCTION; PRONE RAT; OBESITY; DIET;
D O I
10.1111/j.1467-789X.2010.00845.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Diabetes mellitus is a chronic disease requiring lifelong medical attention. With hundreds of millions suffering worldwide, and a rapidly rising incidence, diabetes mellitus poses a great burden on healthcare systems. Recent studies investigating the underlying mechanisms involved in disease development in diabetes point to the role of the dys-regulation of the intestinal barrier. Via alterations in the intestinal permeability, intestinal barrier function becomes compromised whereby access of infectious agents and dietary antigens to mucosal immune elements is facilitated, which may eventually lead to immune reactions with damage to pancreatic beta cells and can lead to increased cytokine production with consequent insulin resistance. Understanding the factors regulating the intestinal barrier function will provide important insight into the interactions between luminal antigens and immune response elements. This review analyses recent advances in the mechanistic understanding of the role of the intestinal epithelial barrier function in the development of type 1 and type 2 diabetes. Given our current knowledge, we may assume that reinforcing the intestinal barrier can offer and open new therapeutic horizons in the treatment of type 1 and type 2 diabetes.
引用
收藏
页码:449 / 458
页数:10
相关论文
共 68 条
  • [1] Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes:: a pilot study
    Åkerblom, HK
    Virtanen, SM
    Ilonen, J
    Savilahti, E
    Vaarala, O
    Reunanen, A
    Teramo, K
    Hämäläinen, AM
    Paronen, J
    [J]. DIABETOLOGIA, 2005, 48 (05) : 829 - 837
  • [2] Physiology and Function of the Tight Junction
    Anderson, James M.
    Van Itallie, Christina M.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2009, 1 (02): : a002584
  • [3] Alterations in intestinal permeability
    Arrieta, M. C.
    Bistritz, L.
    Meddings, J. B.
    [J]. GUT, 2006, 55 (10) : 1512 - 1520
  • [4] The gut microbiota as an environmental factor that regulates fat storage
    Bäckhed, F
    Ding, H
    Wang, T
    Hooper, LV
    Koh, GY
    Nagy, A
    Semenkovich, CF
    Gordon, JI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (44) : 15718 - 15723
  • [5] Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999
    Bessaoud, K.
    Boudraa, G.
    Molinero de Ropolo, M.
    de Sereday, M.
    Marti, M. L.
    Moser, M.
    Lapertosa, S.
    Damiano, M.
    Verge, C.
    Howard, N.
    Schober, E.
    Jordan, O.
    Weets, I.
    Gorus, F.
    Coeckelberghs, M.
    Rooman, R.
    Van Gaal, L.
    Franco, L. J.
    Ferreira, S. R. G.
    Lisboa, H. P. K.
    Kurtz, L. A.
    Graebin, R.
    Kutzke, L.
    Rodriges, C.
    Savova, R.
    Christov, V.
    Iotova, V.
    Tzaneva, V.
    Pacaud, D.
    Toth, E.
    Tan, M. H.
    Carrasco, E.
    Perez, F.
    Ze, Y.
    Bo, Y.
    Chen, S.
    Fu, L.
    Deng, L.
    Shen, S.
    Teng, K.
    Wang, C.
    Jian, H.
    Ju, J.
    Yan, C.
    Ze, Y.
    Deng, Y.
    Li, C.
    Zhang, Y.
    Liu, Y.
    Long, X.
    [J]. DIABETIC MEDICINE, 2006, 23 (08) : 857 - 866
  • [6] Increased intestinal permeability precedes clinical onset of type 1 diabetes
    Bosi, E.
    Molteni, L.
    Radaelli, M. G.
    Folini, L.
    Fermo, I.
    Bazzigaluppi, E.
    Piemonti, L.
    Pastore, M. R.
    Paroni, R.
    [J]. DIABETOLOGIA, 2006, 49 (12) : 2824 - 2827
  • [7] Interferon-γ induces internalization of epithelial tight junction proteins via a macropinocytosis-like process
    Bruewer, M
    Utech, M
    Ivanov, AI
    Hopkins, AM
    Parkos, CA
    Nusrat, A
    [J]. FASEB JOURNAL, 2005, 19 (08) : 923 - 933
  • [8] Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?
    Brugman, S.
    Klatter, F. A.
    Visser, J. T. J.
    Wildeboer-Veloo, A. C. M.
    Harmsen, H. J. M.
    Rozing, J.
    Bos, N. A.
    [J]. DIABETOLOGIA, 2006, 49 (09) : 2105 - 2108
  • [9] Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse
    Calcinaro, F
    Dionisi, S
    Marinaro, M
    Candeloro, P
    Bonato, V
    Marzotti, S
    Corneli, RB
    Ferretti, E
    Gulino, A
    Grasso, F
    De Simone, C
    Di Mario, U
    Falorni, A
    Boirivant, M
    Dotta, F
    [J]. DIABETOLOGIA, 2005, 48 (08) : 1565 - 1575
  • [10] Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding
    Cani, P. D.
    Delzenne, N. M.
    Amar, J.
    Burcelin, R.
    [J]. PATHOLOGIE BIOLOGIE, 2008, 56 (05): : 305 - 309